Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Journal of Pediatric Hematology/Oncology|June 20, 2014
Phase I clinical trial of ifosfamide, oxaliplatin, and etoposide (IOE) in pediatric patients with refractory solid tumorsCatherine G Lam, Wayne L Furman, Chong Wang, et al.Pediatric Blood & Cancer|April 10, 2007
Significance of pleural effusion in neuroblastomaHimesh Gupta, John Conrad, Joseph D Khoury, et al.Cancer|January 23, 2020
A phase 1 trial of everolimus and bevacizumab in children with recurrent solid tumorsVictor M Santana, Natasha Sahr, Ruth G Tatevossian, et al.Journal of Pediatric Surgery|January 22, 2013
Rapamycin increases neuroblastoma xenograft and host stromal derived osteoprotegerin inhibiting osteolytic bone disease in a bone metastasis modelJoseph E Hartwich, W Shannon Orr, Catherine Y Ng, et al.European Journal of Cancer (Oxford, England : 1990)|July 13, 2010
Epidermal growth factor receptor polymorphisms and risk for toxicity in paediatric patients treated with gefitinibTrevor McKibbin, Wei Zhao, Michael Tagen, et al.Journal of Pediatric Surgery|June 19, 2008
Avoiding misdiagnosing neuroblastoma as Wilms tumorPaxton V Dickson, Thomas L Sims, Christian J Streck, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 23, 2023
Chronic pain in children and adolescents diagnosed with cancer: the challenge of mitigating the pain and the potential of integrating exercise into pain managementMaxime Caru, Nicole M Alberts, Michelle C Freeman, et al.Cancer|November 17, 2005
The impact of early resection of primary neuroblastoma on the survival of children older than 1 year of age with stage 4 disease: the St. Jude Children's Research Hospital ExperienceLisa M McGregor, Bhaskar N Rao, Andrew M Davidoff, et al.Journal of Pediatric Surgery|April 14, 2010
Radiation therapy as part of local control of metastatic neuroblastoma: the St Jude Children's Research Hospital experienceJared R Robbins, Matthew J Krasin, Atmaram S Pai Panandiker, et al.Cancer|January 27, 2009
Phase 1 study of oxaliplatin and irinotecan in pediatric patients with refractory solid tumors: a children's oncology group studyLisa M McGregor, Sheri L Spunt, Wayne L Furman, et al.Pageof 3